Feed MOLN.SW
MO
Molecular Partners AG
MOLN.SW · SIX
CHF 3.43 +0.88% (+CHF 0.03)
1M +7.26%
Market Cap CHF 126.4M
P/E Ratio -
Div. Yield -
ROE 66.19%
Bulios Fair Price
CHF 1.87
45.5% downside
Preț actual
CHF 3.43
Subevaluat Valoare justă Supraevaluat
Potrivit Bulios Fair Price, acțiunile MOLN.SW sunt în prezent supraevaluate față de prețul lor de piață. Cum funcționează?
Piotroski F-Score Weak
1/9Valuation
91 /100
Cheap P/B 1.85x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 30.09%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 66.01%
ROE 66.19%
ROA 66.25%
Debt
69 /100
Low Debt/Equity 0.05x
Current ratio 9.42x
Int. coverage -1,812.34x
Stability
28 /100
Unstable Beta 0.68x
Rev. volatility 39.74%
EPS volatility 92.58%
Întreabă StockBot despre MOLN.SW
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Patrick Amstutz
Employees
134
Headquarters
Schlieren
Evenimente viitoare
25 AUG.
Earnings
Upcoming earnings report